Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
In mid-morning trading, the French biotech company is moving downward, contrary to a slightly declining SBF 120. The stock is now at the bottom of the…
DBV Technologies announced on Tuesday its inclusion in the Euronext Tech Leaders index, effective since June 22. This recognition positions the French…
French biotech company DBV Technologies sees a midday decline, contrary to the nearly stable SBF 120. The stock is testing a technical threshold that …
The French biotech continues its technical rebound in a Parisian market buoyed by a significant easing of the VIX. The stock is attempting to build a …
The French biotech regains momentum in a well-oriented Parisian market. The stock attempts to stabilize its price after several weeks of significant d…
The French biotech company continues to decline at mid-session, contrary to a well-oriented Parisian market. The stock is sinking in the lower part of…
DBV Technologies announced on Monday new positive data from its phase 3 VITESSE study and introduced the protocol of its phase 2 THRIVE study, both fo…
French biotech company DBV Technologies will participate on June 9 in the 47th annual Global Healthcare Conference organized by Goldman Sachs in Miami…
The French biotech company experiences another session of decline, while the Paris market also closes in negative territory. The stock continues its s…
DBV Technologies announces the screening of the first participant in the phase 2 THRIVE clinical study, which assesses the efficacy and safety of the …
